Cancer Heterogeneity and Cancer Cell Plasticity: Molecular Mechanisms and Precision Therapy.

Area of Science:

• Oncology
• Cancer Biology
• Genomics

Background:

• Tumor heterogeneity and cancer cell plasticity are key drivers of cancer progression, therapeutic resistance, and recurrence.
• These processes limit the effectiveness and durability of current precision oncology strategies.
• Understanding the interplay between heterogeneity and plasticity is crucial for developing more effective cancer treatments.

Purpose of the Study:

• To synthesize recent advances in understanding tumor heterogeneity and cancer cell plasticity.
• To discuss the role of the tumor microenvironment in regulating cancer cell plasticity.
• To propose a next-generation precision oncology paradigm to overcome treatment resistance.

Main Methods:

• Review of current literature on tumor heterogeneity, cancer cell plasticity, and the tumor microenvironment.
• Analysis of challenges in precision therapy, including target loss, bypass pathway activation, and adaptive cell-state transitions.
• Discussion of emerging technologies like single-cell and spatial multiomics and artificial intelligence.

Main Results:

• Tumor heterogeneity and plasticity are intrinsically linked, driving tumor progression and therapeutic resistance.
• The tumor microenvironment significantly influences cancer cell plasticity through various cues.
• Cancer cell plasticity is a major contributor to heterogeneous therapeutic efficacy and drug resistance.

Conclusions:

• A next-generation precision oncology paradigm integrating stratified diagnosis, combination interventions, and adaptive monitoring is proposed.
• The development of "digital twin" tumor models using multiomics and AI can guide individualized treatment decisions.
• Addressing tumor heterogeneity and plasticity is essential for improving long-term cancer patient outcomes.